Status:
COMPLETED
Circulating IL-6, Clusterin and Irisin in Obese Subjects
Lead Sponsor:
Rehab Werida
Collaborating Sponsors:
Tanta University
Conditions:
Obesity
Eligibility:
All Genders
20-45 years
Brief Summary
evaluate the circulating levels of IL-6, clusterin and irisin in obese subjects of both sexes who had different classes of obesity and their sexual dimorphism also identify the association of IL-6, cl...
Detailed Description
Aim: Firstly, this study aimed at assessing the circulating levels of IL-6, clusterin and irisin in obese subjects of both sexes who had different classes of obesity and evaluating their sexual dimorp...
Eligibility Criteria
Inclusion
- Healthy Female and Male
- Age matched adult non-diabetic non-smoker males and females'
Exclusion
- smokers, subjects with a history of diabetes mellitus, liver, renal, thyroid, inflammatory diseases, and females on contraceptives pills. Patients on medications that can interfere with glucose or lipid metabolism (corticosteroids, anti-hyperlipidemics, non-selective beta blockers, thiazides, etc.) and subjects with organic causes of obesity were also excluded from this study.
Key Trial Info
Start Date :
February 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2019
Estimated Enrollment :
176 Patients enrolled
Trial Details
Trial ID
NCT04133896
Start Date
February 1 2018
End Date
June 30 2019
Last Update
October 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University
Tanta, El-Gharbia, Egypt, 31527